Harry Fitzpatrick is currently working as an Investment Executive in the Health & Life Sciences Investment Team at Synova since November 2021. Prior to this, Harry worked as an Origination Analyst in the Health & Life Sciences division at Goldman Sachs. Before that, Harry was a Trader in Equity derivatives at Goldman Sachs. Harry started their career at Goldman Sachs as a Securities Division Spring Intern in 2018 and later worked as a Securities Division Summer Analyst in 2019. Harry holds a MChem degree in Chemistry from the University of Oxford, where they attended from 2016 to 2020.
March, 2023 - present
Investment Executive at LDC
Investment Executive at Bowmark Capital
Sr. Investment Executive at Western International Securities
Investment Executive Director at Infranity
Investment Executive, Global Credit Solutions at MA Financial Group
Access the worlds's biggest network of public org charts
Learn more